All News

While Agent Orange, an herbicide used during the Vietnam War, has been previously linked to a variety of types of cancers in Vietnam veterans, new data from the Veterans Affairs Medical Center in Shreveport, LA, indicates that there may be a connection between veterans? in-country exposure and subsequent development of renal cancer.

BK Medical is showcasing what it?s calling the industry?s first complete ultrasound imaging solution for robot-assisted surgery at this week?s AUA annual meeting.

Results of a retrospective study investigating men with clinically localized prostate cancer who underwent radical retropubic prostatectomy with bilateral pelvic lymph node dissection (PLND) show a higher than expected incidence of LN metastases, but men with nodal involvement had excellent 10-year clinical recurrence-free survival.

Among men receiving early androgen deprivation therapy (ADT) for biochemical recurrence after radical prostatectomy, obesity appears to be a significant risk factor for poorer prognosis, according to the results of a retrospective study presented yesterday.

Despite the absence of long-term outcomes, the use of robots in radical prostatectomy is growing exponentially and producing very acceptable short- and intermediate-term outcomes.

Bladder cancer control outcomes have not improved in the United States within the last 30 years, according to a trend analysis presented by Firas Abdollah, MD.

A new iPad application developed by urologic surgeons allows physicians to use detailed interactive imagery to illustrate and describe treatment options for medical conditions.

Much of the literature suggests that the majority of extraperitoneal bladder injuries seen in trauma facilities can be managed conservatively. A study from the University of Utah greets that position with a degree of skepticism.

The urethral strictures and fistulas that sometimes follow localized prostate cancer treatments can be challenging, but skill and experience can often overcome the challenge, according to a study from the University of Colorado Hospital, Aurora, presented yesterday.

Use of non-hospital ambulatory facilities as the setting for common outpatient urologic procedures does not appear to adversely affect short-term patient morbidity or mortality, according to researchers from the University of Michigan, Ann Arbor.

Behavioral therapy can net significant improvements for men with incontinence post-radical prostatectomy, even in patients 5 years removed from surgery.

Results from a retrospective exploratory study of patients with urge incontinence and detrusor overactivity suggest that leakage and the pressure at which it occurs have potential predictive and therapeutic value.

The synergy between two large NIDDK-sponsored studies and pharmaceutical research will soon bring new treatments and etiologic insight to interstitial cystitis/bladder pain syndrome.

Web-based communication has become increasingly important for creating a more effective patient experience.

Cutting-edge research in andrology is changing the way urologists who specialize in male infertility ply their craft.

Urologists attending localized prostate cancer sessions at the upcoming AUA annual meeting in Washington will hear more about the ongoing debate on open versus minimally invasive radical prostatectomy, the use of 5-alpha-reductase inhibitors (5-ARIs) in men on active surveillance, and updates on treatment approaches such as high-intensity focused ultrasound.

Continuing progress in the area of tissue engineering holds the greatest potential impact, not just in pediatric urology or even the entire specialty, but for medicine and society as a whole.

Results from analyses of urodynamics data collected in the Trial of Mid-urethral Slings show some parameters change significantly after surgery.

Advancing technology is pushing clinicians and patients into making ever more nuanced decisions between the costs of a procedure and its value.

In the area of urologic infections and inflammation, research to be presented at this year's AUA annual meeting in Washington will highlight an ongoing trend toward understanding and attempting to modify the human microbiologic environment for patients' benefit.

Multiple presentations at the 2011 AUA annual meeting will highlight associations between nephrolithiasis and systemic conditions, including cardiovascular disease.

Of the many questions raised by the advent of robot-assisted surgery, two are germane to robotic sacrocolpopexy: Does the technology increase the risk of stress urinary incontinence in women undergoing the robotic procedure, and if it does, should an anti-incontinence procedure accompany the primary procedure as prophylaxis against incontinence?

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase I and II localized prostate cancer trials that are currently recruiting participants as well as phase IV U.S. incontinence/overactive bladder trials. This list is current as of April 22, 2011. more information, view the complete database at http://ClinicalTrials.gov.

Research investigating the ability to detect low levels of circulating tumor cells and to correlate their quantity with clinicopathologic parameters in men with advanced prostate cancer who have undergone surgery or radiotherapy is still at an early stage, but the initial results suggest this method has promising prognostic value.

A number of the leading studies that focus on the epidemiology, etiology, and treatment of BPH and lower urinary tract symptoms being presented at the upcoming AUA annual meeting seem to be characterized more by the questions they raise than by those they answer.

The newest urology products and services from IPC Medical Corp., Mission Pharmacal, Microline Surgical, Inc., the American Medical Group Association, Uramix, Inc., WellComm, and Graceway Pharmaceuticals, Inc.

Urology drugs and devices that are in the pipeline from immatics biotechnologies GmbH, Neotract Inc., Abbott Laboratories, and Beech Tree Labs, Inc.

A retropubic mid-urethral sling showed a success rate of 81% and a satisfaction rate of 78% at an average follow-up of 68 months (range, 60-88 months) in a recent study.